GARBARINO, OMBRETTA
 Distribuzione geografica
Continente #
EU - Europa 826
Totale 826
Nazione #
IT - Italia 826
Totale 826
Città #
Genova 429
Genoa 167
Rapallo 164
Vado Ligure 65
Bordighera 1
Totale 826
Nome #
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 123
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 98
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 97
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 91
Investigating PLX4032 resistance in a human melanoma cell line: a question of metabolism 77
Characterization of metabolic and molecular response of a human melanoma cell line resistant to PLX4032 69
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 68
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 66
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 55
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. 49
PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism 42
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 20
Totale 855
Categoria #
all - tutte 3.573
article - articoli 3.325
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020164 0 0 0 0 17 17 27 17 16 42 23 5
2020/202178 0 7 3 6 11 4 7 13 6 8 8 5
2021/2022154 9 8 3 38 13 15 2 24 9 13 2 18
2022/2023199 11 21 3 29 19 28 0 14 25 0 45 4
2023/2024131 4 10 5 22 28 17 3 7 2 13 9 11
2024/202572 11 16 1 35 9 0 0 0 0 0 0 0
Totale 855